Treatment for Distant Metastasis

.bdt-divider-icon{--wpr-bg-aad670e9-acf8-4218-9691-481f5f057c11: url('https://mestastop.com/wp-content/plugins/bdthemes-prime-slider-lite/images/backgrounds/divider-icon.svg');}.bdt-list-bullet>::before{--wpr-bg-47514315-43b6-4403-a1e7-4333216cb963: url('https://mestastop.com/wp-content/plugins/bdthemes-prime-slider-lite/images/backgrounds/list-bullet.svg');}.bdt-input[list]:hover,.bdt-input[list]:focus{--wpr-bg-88b906b5-1bd8-413c-a9e1-66a2e36938c4: url('https://mestastop.com/wp-content/plugins/bdthemes-prime-slider-lite/images/backgrounds/form-datalist.svg');}.everest-forms .blockUI.blockOverlay::before{--wpr-bg-de725971-17e4-4050-b836-e4246f1c227c: url('https://mestastop.com/wp-content/plugins/everest-forms/assets/images/icons/loader.svg');}.everest-forms .loader::before{--wpr-bg-a1510731-2600-42ef-a0fb-036a27dcf585: url('https://mestastop.com/wp-content/plugins/everest-forms/assets/images/icons/loader.svg');}.lg-outer .lg-item{--wpr-bg-ecfe5b5f-a9f9-492c-a5c3-27050ae69d53: url('https://mestastop.com/wp-content/themes/onepress/assets/images/loading.gif');}.elementor-10 .elementor-element.elementor-element-83f3857 .elementor-repeater-item-4efa204 .swiper-slide-bg{--wpr-bg-68c2b598-634d-4b3d-9717-a44cb084ab2b: url('https://mestastop.com/wp-content/uploads/2024/12/Picture1.png');}.elementor-10 .elementor-element.elementor-element-83f3857 .elementor-repeater-item-ebdecc0 .swiper-slide-bg{--wpr-bg-a8972be8-6750-429a-b183-c8f56a5c4756: url('https://mestastop.com/wp-content/uploads/2025/05/Screenshot-2025-05-16-184041.png');}.elementor-10 .elementor-element.elementor-element-83f3857 .elementor-repeater-item-89bc545 .swiper-slide-bg{--wpr-bg-0639d10e-e44c-403f-9d82-c4386cfca76c: url('https://mestastop.com/wp-content/uploads/2025/04/5.webp');}table.dataTable thead .sorting{--wpr-bg-8f893700-af02-434c-b4ed-375bd17013c9: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/arrow.png');}table.dataTable thead .sorting_asc{--wpr-bg-91169627-2b9c-45f7-9843-a14def244923: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/sort_asc.png');}table.dataTable thead .sorting_desc{--wpr-bg-ec9c917a-24d7-48e3-bb0b-b28f6a39bbb4: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/sort_desc.png');}table.dataTable thead .sorting_asc_disabled{--wpr-bg-0bfbe084-469f-476a-aa5f-fe428bafdff1: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/sort_asc_disabled.png');}

We are
the
Metastasis Specialists

Read More
Unravelling Metastasis,
the last frontier of Cancer with
in-vitro, in-vivo and patient ex-vivo
Platform Technology

Read More
Research Oncology Solutions
Uniquely Leveraging Technology
For
Drug discovery, Repurposing, Companion Diagnostics

Read More

Refer our latest white paper discussing "Patient-centric approach for drug repurposing using two strategies"

Drug Discovery

Identification Of Novel-First-In-Class Targets In Translational Settings.

Drug Repurposing

Combination of in-vitro, in-vivo, ex-vivo and retrospective clinical trials to identify safest Candidates to delay metastasis in adjuvant settings.

Clinical Translation

Machine learning-powered patented biochemical approach to ensure patient relevance for accurate pre-clinical study design, significantly enhancing probability of clinical trial success.

We are
the
Metastasis Specialists

Unravelling Metastasis,
the last frontier of Cancer with
in-vitro, in-vivo and patient ex-vivo
Platform Technology

Research Oncology Solutions
Uniquely Leveraging Technology
For
Drug discovery, Repurposing, Companion Diagnostics

Drug Discovery

Identification Of Novel-First-In-Class Targets In Translational Settings.

Drug Repurposing

Combination of in-vitro, in-vivo, ex-vivo and retrospective clinical trials to identify safest Candidates to delay metastasis in adjuvant settings.

Clinical Translation

Machine learning-powered patented biochemical approach to ensure patient relevance for accurate pre-clinical study design, significantly enhancing probability of clinical trial success.

Latest News Updates!

Mestastop Solutions applies to CDSCO for approval of Ph II clinical trial targeting metastasis

This technology helps researchers fight the deadliest aspect of cancer!

We are the Metastasis Specialists

Unravelling Metastasis, the last frontier of Cancer with in-vitro, in-vivo and patient ex-vivo Platform Technology

Research Oncology Solutions Uniquely Leveraging Technology For Drug discovery, Repurposing, Companion Diagnostics

Drug Discovery

Identification Of Novel-First-In-Class Targets In Translational Settings.

Drug Repurposing

Combination of in-vitro, in-vivo, ex-vivo and retrospective clinical trials to identify safest Candidates to delay metastasis in adjuvant settings.

Clinical Translation

Machine learning-powered patented biochemical approach to ensure patient relevance for accurate pre-clinical study design, significantly enhancing probability of clinical trial success.

Latest News Updates!

Mestastop Solutions applies to CDSCO for approval of Ph II clinical trial targeting metastasis

This technology helps researchers fight the deadliest aspect of cancer!

We are
the
Metastasis Specialists

Unravelling Metastasis,
the last frontier of Cancer with
in-vitro, in-vivo and patient ex-vivo
Platform Technology

Research Oncology Solutions
Uniquely Leveraging Technology
For
Drug discovery, Repurposing, Companion Diagnostics